نتایج جستجو برای: bovine lymphocyte antigen

تعداد نتایج: 315388  

Journal: :The Journal of Experimental Medicine 2007
Menno C. van Zelm Tomasz Szczepański Mirjam van der Burg Jacques J.M. van Dongen

The contribution of proliferation to B lymphocyte homeostasis and antigen responses is largely unknown. We quantified the replication history of mouse and human B lymphocyte subsets by calculating the ratio between genomic coding joints and signal joints on kappa-deleting recombination excision circles (KREC) of the IGK-deleting rearrangement. This approach was validated with in vitro prolifera...

Journal: :Journal of immunotherapy 2015
Jason N Crosson Philip W Laird Matthew Debiec Chris S Bergstrom David H Lawson Steven Yeh

Cytotoxic T-lymphocyte-associated antigen is a naturally occurring inhibitor of T-cell costimulation. Monoclonal antibody inhibition of cytotoxic T-lymphocyte-associated antigen with ipilimumab blocks this negative regulator of costimulation, promoting T-cell activation and survival, and leads to melanoma regression. Findings of the Vogt-Koyanagi-Harada (VKH) syndrome, an uveomeningitic syndrom...

Journal: :The Journal of Experimental Medicine 1998
Akio Matsuda Satoshi Motoya Shioko Kimura Renee McInnis Abby L. Maizel Akiko Takeda

CD45-AP specifically associates with CD45, a protein tyrosine phosphatase essential for lymphocyte differentiation and antigen receptor-mediated signal transduction. CD45 is thought to mediate antigen receptor signaling by dephosphorylating regulatory tyrosine residues on Src family protein tyrosine kinases such as Lck. However, the mechanism for regulating CD45 protein tyrosine phosphatase act...

Ali Akbar Gorzin, Alijan Tabarraei, Amir Ghaemi, Naser Behnampour, Shiva Irani, Zahra Gorzin,

Backgrounds: Most of the hepatitis C virus (HCV) infections elicit poor immune responses and 75% to 85% of cases become chronic therefore, the development of an effective vaccine against HCV is of paramount importance. In this study, we aimed to evaluate co-administration of HCV non-Structural Protein 2 and IL-12 DNA vaccines in C57BL/6 mice. Methods: A plasmid encoding full-length HCV NS2 prot...

Journal: :Cancer immunology research 2014
Laura J Vella Anupama Pasam Nektaria Dimopoulos Miles Andrews Ashley Knights Anne-Laure Puaux Jamila Louahed Weisan Chen Katherine Woods Jonathan S Cebon

Combination therapy with BRAF and MEK inhibition is currently in clinical development for the treatment of BRAF-mutated malignant melanoma. BRAF inhibitors are associated with enhanced antigen-specific T-lymphocyte recognition in vivo. Consequently, BRAF inhibition has been proposed as proimmunogenic and there has been considerable enthusiasm for combining BRAF inhibition with immunotherapy. ME...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2015
Safa Mellak Hafid Ait-Oufella Bruno Esposito Xavier Loyer Maxime Poirier Thomas F Tedder Alain Tedgui Ziad Mallat Stéphane Potteaux

OBJECTIVE Abdominal aortic aneurysm (AAA) is widespread among elderly people and results in progressive expansion and rupture of the aorta with high mortality. Macrophages, which are the main population observed within the site of aneurysm, are thought to derive from circulating monocytes although no direct evidence has been provided to date. In this study, we were particularly interested in un...

Journal: :iranian biomedical journal 0
نادر شاهرخی nader shahrokhi انیس جعفری anis jafari jorg reimann valery v bakayev reinhold schirmbeck valery v bakayev jorg reimann سعید بوذری saeid bouzari

hepatitis b surface antigen is the first genetically engineered vaccine licensed for human use. various strategies have been proposed to obtain a vaccine that would bypass the need for injection. in this study, a non-toxic portion of heat-stable enterotoxin of escherichia coli that is capable of adhering to epithelial cells was inserted at amino acid position 112 of hepatitis surface antigen. t...

Cancer immunotherapy has gained a lot of interest over the past few years due to the success of immune checkpoint inhibitors in treating cancer (1, 2). Immune checkpoint inhibitors, such as monoclonal antibodies against cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) and programmed death 1 (PD-1), have been shown to increase survival of patients with advanced cancers (1, 2). These in...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید